Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The prevalence of type 2 diabetes is significantly increased in the pediatric population, which is affected by obesity worldwide. The progression from normal glucose tolerance (NGT) to type 2 diabetes involves intermediate stages of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also known as prediabetes. The pathophysiology underlying the development of these glucose metabolic alterations is multifactorial; however an alteration in the balance between insulin sensitivity and insulin secretion represents the most important player in the development of type 2 diabetes. Obese children and adolescents affected by IGT and type 2 diabetes are characterized by severe insulin resistance, which is associated with an increased lipid accumulation in visceral compartments, liver and muscle tissues and by reduced sensitivity of I²-cell of first and second-phase insulin secretion. The progression in obese children of insulin resistance to type 2 diabetes has been shown to be faster than in adults; in addition, type 2 diabetes is already associated with several metabolic and cardiovascular complications in this age group. In the present review, we summarize the most recent findings concerning the prevalence of type 2 diabetes in youth and in particular we explore the pathophysiology of type 2 diabetes and the natural history of this pathology in obese children and adolescents. Concurrent with the worldwide epidemic increase of childhood obesity, type 2 diabetes and the two prediabetic conditions, IFG and IGT, are becoming increasingly more common in obese children and adolescents (1,2). Until 10 years ago, type 2 diabetes accounted for less than 3% of all cases of new-onset diabetes in adolescents. At present 45% of cases are attributed to it (3,4). Type 2 diabetes occurs in youth more often during the second decade of life, coinciding with the physiological occurrence of pubertal insulin resistance (1). In addition, …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 A: Baseline values of the dynamic β-cell responsivity (Φd) in subjects who maintained NGT (nonprogressors [NP]) and in subjects who developed IGT (progressors [P]) (P = 0.04). B: Changes of the DI values according to changes in glucose tolerance over the course of approximately 30 months. Subjects who developed IGT (progressors) experienced a progressive decline of overall β-cell function, as assessed by the DI. OGTT, oral glucose tolerance test.*P = 0.04.](https://figures.cochat.ai/paper-figures/cb715871c23742ee9f771e1551b9fb72/type-2-diabetes-in-youth-epidemiology-and-pathophysiology-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Staggeringly, 80% of all new diabetes cases in Japan in children and adolescents were reported as T2D and other countries have also reported an increase in youth T2D.60”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [60]
In the citing paper
“However, many studies from Europe have reported that youth T2D is much rarer, accounting for only 1–2% of all diabetes mellitus cases.55,60”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“The ability of the b-cell to secrete sufficient insulin to adequately respond to the peripheral insulin resistance state depends on multiple factors, including b-cell mass (14) and secretory capacity (14), which are influenced by genetic (15) and environmental factors (15).”
BackgroundDeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · cited 1×
“Although it remains unclear whether hepatic steatosis is a consequence or a cause of derangements in insulin sensitivity, the presence of steatosis is an important marker of multiorgan insulin resistance (29); moreover, insulin resistance is directly related to percent liver fat (29).”
BackgroundPrevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“In particular, 25% of children and 21% adolescents with severe degree of obesity, irrespective of ethnicity, were found to have IGT (10).”
BackgroundSelf-citationImpaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Incidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Despite the demonstrated relationship between IMCL, visceral fat, and metabolic dysfunction, the ectopic fat deposition in the liver is emerging as the most important marker of insulin resistance and glucose dysregulation in adults (27) as well as in obese pediatric population (28).”
BackgroundClinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Type 2 Diabetes in Children and Adolescents
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.035 · Cited by 926
Cited by
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Thomas, M. C., Cooper, M. E., & Zimmet, P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.173 · Cited by 742
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Chandrasekaran, P., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031882 · Cited by 465
“Recently, different drugs have been approved to improve type 2 DM and promote weight loss such as GLP-1 receptor agonists and SGLT2 inhibitors [4].”
BackgroundReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Obesity and diabetes—Not only a simple link between two epidemics
Chobot, A., Górowska‐Kowolik, K., Sokołowska, M., & Jarosz‐Chobot, P. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3042 · Cited by 281
Ward, R., Li, W., Abdul, Y., Jackson, L., Dong, G., Jamil, S., Filosa, J., Fagan, S. C., & Ergul, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.035 · Cited by 270
Early onset type 2 diabetes: risk factors, clinical impact and management
Wilmot, E., & Idris, I. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314548679 · Cited by 269
Role of microRNAs in obesity and obesity-related diseases
Iacomino, G., & Siani, A. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0577-z · Cited by 226
“Dyslipidemia and type 2 diabetes (T2D) have exhibited a corresponding increase over the same time span also in children [6].”
BackgroundType 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis
Galling, B., Roldán, A., Nielsen, R. E., Nielsen, J., Gerhard, T., Carbon, M., Stubbs, B., Vancampfort, D., De Hert, M., Olfson, M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2923 · Cited by 224
Fazeli Farsani, S., van der Aa, M. P., van der Vorst, M. M. J., Knibbe, C. A. J., & de Boer, A. (2013) · Diabetologia · doi:10.1007/s00125-013-2915-z · Cited by 211
“In addition, (severe) complications of type 2 diabetes, such as nephropathy, retinopathy, neuropathy, dyslipidaemia and cardiovascular disease are an ongoing threat [4 – 7].”
Brannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177
“The increasing prevalence affects children and adolescents as well, especially the obese pediatric population.(3) Diabetes is the leading cause of blindness, amputation, and end-stage kidney disease, and is associated with an approximately two- to four-fold increased risk of myocardial infarction and stroke.”
BackgroundAbbasi, A., Juszczyk, D., van Jaarsveld, C. H. M., & Gulliford, M. C. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00044 · Cited by 165
A Review of Rodent Models of Type 2 Diabetic Skeletal Fragility
Fajardo, R. J., Karim, L., Calley, V. I., & Bouxsein, M. L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2210 · Cited by 164
Early onset type 2 diabetes mellitus: an update
Strati, M., Moustaki, M., Psaltopoulou, T., Vryonidou, A., & Paschou, S. A. (2024) · Endocrine · doi:10.1007/s12020-024-03772-w · Cited by 148
“In fact, intrahepatic fat, which is emerging as the most important marker of insulin resistance, is threefold higher compared to later-onset T2DM and BMI-matched peers without diabetes [2, 19].”
BackgroundAlderete, T. L., Habre, R., Toledo-Corral, C. M., Berhane, K., Chen, Z., Lurmann, F. W., Weigensberg, M. J., Goran, M. I., & Gilliland, F. D. (2017) · Diabetes · doi:10.2337/db16-1416 · Cited by 158
“, prediabetes and type 2 diabetes have dramatically increased in adult populations and have become more frequent in obese youth (1,2), presenting pressing clinical and public health problems.”
BackgroundDNA methylation and its role in the pathogenesis of diabetes
Bansal, A., & Pinney, S. E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12521 · Cited by 171
“T2DM is the most common type of diabetes in adults, but increasingly has also been diagnosed in youth.(7) A recent report by the US National Diabetes Statistics highlighted the estimated annual cost of all forms of diabetes in the United States alone to be $245 billion.”
BackgroundRato, L., Duarte, A. I., Tomás, G. D., Santos, M. S., Moreira, P. I., Socorro, S., Cavaco, J. E., Alves, M. G., & Oliveira, P. F. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.12.008 · Cited by 153
“Contents lists available at ScienceDirect Biochimica et Biophysica Acta j ourna l homepage: www.e lsev ie r .com/ locate /bbab io Pre-diabetes alters testicular PGC1-α/SIRT3 axis modulating mitochondrial bioenergetics and oxidative stress Luís Rato a,b, Ana I. Duarte b,c, Gonçalo D. Tomás a, Maria S. Santos b,d, Paula…”
BackgroundInfluentialWang, S. Y., Andrews, C. A., Herman, W. H., Gardner, T. W., & Stein, J. D. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2016.10.031 · Cited by 152
“Whereas in past decades the great majority of youths with diabetes mellitus (DM) had T1DM, T2DM now accounts for nearly one half of all new DM diagnoses among adolescents, concurrent with the rise of childhood obesity.(4,5) Diabetic retinopathy (DR) is a serious complication that is often asymptomatic in early stages…”
BackgroundPathophysiology of Type 2 Diabetes in Children and Adolescents
Valaiyapathi, B., Gower, B. A., & Ashraf, A. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180608074510 · Cited by 191
Hypoglycemic agents and potential anti-inflammatory activity
Mathews, S. T., Kothari, V. M., & Galdo, J. A. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86917 · Cited by 158
Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity
Al‐Rawaf, H. A. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.024 · Cited by 132
Inadequate sleep as a contributor to type 2 diabetes in children and adolescents
Dutil, C., & Chaput, J.-P. (2017) · Nutrition & Diabetes · doi:10.1038/nutd.2017.19 · Cited by 117
Developmental overnutrition and obesity and type 2 diabetes in offspring
Perng, W., Oken, E., & Dabelea, D. (2019) · Diabetologia · doi:10.1007/s00125-019-4914-1 · Cited by 129
Care of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99
Extracellular vesicles as signaling mediators in type 2 diabetes mellitus
Hooten, N. N., & Evans, M. K. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00536.2019 · Cited by 101
Pathirana, M. M., Lassi, Z. S., Roberts, C. T., & Andraweera, P. H. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174419000850 · Cited by 86
Hirahatake, K. M., Slavin, J. L., Maki, K. C., & Adams, S. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.009 · Cited by 86
“During this time, the percentage of pediatric cases of diabetes classified as T2D has risen from less than 3% to 45% [6].”
Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update
Bashir, U., Sharma, N., Satija, S., Mehta, M., Vyas, M., Khatik, G. L., Khurana, N., Hansbro, P. M., Williams, K. A., & Dua, K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190717104547 · Cited by 92
Wan, Y., Xia, J., Xu, J., Chen, L., Yang, Y., Wu, J., Tang, F., Ao, H., & Peng, C. Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106002 · Cited by 93
Nutritional Recommendations for Individuals with Diabetes
Gray, A., & Threlkeld, R. J. (2015) · Europe PMC (PubMed Central) · Cited by 93
Jastreboff, A. M., Lacadie, C., Seo, D., Kubat, J., Van Name, M. A., Giannini, C., Savoye, M., Constable, R. T., Sherwin, R. S., Caprio, S., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0525 · Cited by 83
Self-citationMohan, V., Amutha, A., Ranjani, H., Unnikrishnan, R., Datta, M., Anjana, R. M., Staimez, L., Ali, M. K., & Narayan, K. M. V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0259 · Cited by 82
“40 This may be particularly relevant in relatively leaner populations like South Asians.”
Selenium Status and Its Antioxidant Role in Metabolic Diseases
Huang, J., Xie, L., Song, A., & Zhang, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7009863 · Cited by 96
“Recently, this practice has achieved promising results in the prevention and treat-ment of metabolic diseases, including CHD, HT, NAFLD, and T2DM [6, 79 – 82].”
InfluentialSant, K. E., Jacobs, H. M., Borofski, K. A., Moss, J. B., & Timme-Laragy, A. R. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2016.10.057 · Cited by 79
“Incidence of diabetes and metabolic syndrome, especially among children, has been rapidly increasing in the United States, presenting an emerging public health and economic crisis (D’Adamo and Caprio, 2011; Dabelea et al., 2014; Li et al., 2009; Silverstein et al., 2005).”
BackgroundAtrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease
Jansen, H. J., Bohne, L. J., Gillis, A. M., & Rose, R. A. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.05.002 · Cited by 74
Dairy products, yogurt consumption, and cardiometabolic risk in children and adolescents
Moreno, L. A., Bel‐Serrat, S., Santaliestra-Pasías, A. M., & Bueno, G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv014 · Cited by 84
“A decade ago, type 2 diabetes accounted for <3% of all new cases of diabetes in adolescents; today, type 2 diabetes accounts for approximately 45% of new cases.(8) Some studies have suggested that dairy consumption and its contribution to calcium intake may have a protective effect against the development of CVD.”
Age-related differences in glycaemic control in diabetes
Selvin, E., & Parrinello, C. M. (2013) · Diabetologia · doi:10.1007/s00125-013-3078-7 · Cited by 82
“Persons diagnosed with type 2 diabetes at younger ages may have a more severe form of the disease, associated with a higher degree of insulin resistance, more rapidly increasing glucose levels, and worse glycaemic control that is more resistant to current treatment modalities [16].”
BackgroundSchievink, B., Kröpelin, T., Mulder, S., Parving, H. ‐., Remuzzi, G., Dwyer, J., Vemer, P., de Zeeuw, D., & Lambers Heerspink, H. J. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12583 · Cited by 72
“Likewise, the incidence of type 2 diabetes is markedly increasing in paediatric and adolescent populations [14,15,34].”
BackgroundChan, C. L., Pyle, L., Newnes, L., Nadeau, K. J., Zeitler, P. S., & Kelsey, M. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3612 · Cited by 70
Etiology of insulin resistance in youth with type 2 diabetes
Cree-Green, M., Triolo, T. M., & Nadeau, K. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0341-0 · Cited by 69
“Secretion of insulin is dependent on beta-cell mass and secretory capacity, that are both governed by genetic and environmental factors, including increased FFA levels [1, 66, 71].”
BackgroundInfluentialMedical Management of Diabesity: Do We Have Realistic Targets?
Pappachan, J. M., & Viswanath, A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0828-9 · Cited by 80
“If the glycemic targets are not achieved, the clinician should always revisit the existing management plan/patient compliance and revise the 4 Page 6 of 10 Curr Diab Rep (2017) 17: 4”
BackgroundTsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 63
“A significant body of research has focused on pediatric obesity, highlighting the important role that excess adiposity in young age may be implicated in the future development of T2DM and related comorbidities [86].”
BackgroundTeló, G. H., Cureau, F. V., Szklo, M., Bloch, K. V., & Schaan, B. D. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12828 · Cited by 70
Corte, K. W. D., Fife, J., Gardner, A. M., Murphy, B. L., Kleis, L., Corte, D. D., Schwingshackl, L., LeCheminant, J. D., & Buyken, A. E. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa070 · Cited by 69
Cree-Green, M., Gupta, A., Coe, G. V., Baumgartner, A. D., Pyle, L., Reusch, J. E. B., Brown, M. S., Newcomer, B. R., & Nadeau, K. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.014 · Cited by 56
“intramyocellular lipid (IMCL), intraheptic lipid and lipid subspecies such as diacyglycerol may be related to IR (8, 13, 14).”
BackgroundOphthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network
Wang, S. Y., Andrews, C. A., Gardner, T. W., Wood, M., Singer, K., & Stein, J. D. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0089 · Cited by 56
Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents
Inge, T. H., Prigeon, R. L., Elder, D. A., Jenkins, T. M., Cohen, R. M., Xanthakos, S. A., Benoit, S. C., Dolan, L. M., Daniels, S. R., & D'Alessio, D. A. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.020 · Cited by 55
Studentsova, V., Mora, K. E., Glasner, M. F., Buckley, M. R., & Loiselle, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-27634-4 · Cited by 54
Complications of Acute and Chronic Hyperglycemia
Marcovecchio, M. L. (2017) · US Endocrinology · doi:10.17925/use.2017.13.01.17 · Cited by 67
Ward, R., Valenzuela, J. P., Li, W., Dong, G., Fagan, S. C., & Ergul, A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00390.2018 · Cited by 51
“Although ischemic stroke and cognitive impairment are considered diseases of the elderly, an alarming increase in the number of younger patients diagnosed with diabetes also brings the increased risk for stroke and cognitive impairment at relatively earlier ages (6, 11, 13, 26).”
BackgroundDiabetes complications in childhood and adolescent onset type 2 diabetes—a review
Amutha, A., & Mohan, V. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.009 · Cited by 61
Vascular Complication in Adolescents With Diabetes Mellitus
Graves, L. E., & Donaghue, K. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00370 · Cited by 56
Hypoglycemic, Hypolipidemic, and Anti-Inflammatory Effects of Beta-Pinene in Diabetic Rats
Santos, E. S., Coelho, G. L. A., Loula, Y. K. S. F., Landim, B. L. S., Lima, C. N. F., Machado, S. T. D. S., Lopes, M. J. P., Gomes, A. D. S., da Costa, J. G. M., de Menezes, I. R. A., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8173307 · Cited by 56
Screening for cardiovascular disease risk factors beginning in childhood
Bloetzer, C., Bovet, P., Surís, J.-C., Siméoni, U., Paradis, G., & Chioléro, A. (2015) · Public health reviews · doi:10.1186/s40985-015-0011-2 · Cited by 58
“[23–25].”
BackgroundSjaarda, L. A., Michaliszyn, S. F., Lee, S., Tfayli, H. M., Bacha, F. F., Farchoukh, L. O., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0747 · Cited by 50
“In addition, we (12,13) and others (30,31) have reported progressively declining DI across the spectrum of glycemia from normal to IFG and/or IGT to type 2 diabetes in youth.”
BackgroundAcanthosis nigricans in obese adolescents: prevalence, impact, and management challenges
Ng, H. Y. (2016) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s103396 · Cited by 58
Challenges in diagnosis and management of diabetes in the young
Unnikrishnan, R., Shah, V. N., & Mohan, V. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0036-6 · Cited by 47
“The increase in prevalence of T2D is closely linked to the epidemic of obesity affecting youth in many countries across the world [20].”
BackgroundChronic Care Nursing: A Framework for Practice
Deravin, L. M., & Anderson, J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316544341 · Cited by 42
Diabetes and Insulin Resistance in Pediatric Obesity
Kim, G. J., & Caprio, S. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.09.002 · Cited by 51
Self-citationJeffery, S. C., Hosking, J., Jeffery, A., Murphy, M. J., Voss, L. D., Wilkin, T. J., & Pinkney, J. H. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12571 · Cited by 46
Li, Y., Chen, Q., Liu, Y., Bi, L., Jin, L., Xu, K., & Peng, R. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01731-2 · Cited by 47
“In the past 30 years, the prevalence of DM has shown a trend of younger age as the number of young people with type 2 diabetes mellitus (T2DM) has increased significantly, which has gradually become a threat to the health of young people [5, 6].”
BackgroundGu, A., Kamat, S., & Argulian, E. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.019 · Cited by 42
Valdez-Ortiz, R., Navarro-Reynoso, F. P., Olvera-Soto, G., Alemañy, G. M., Rodriguez-Matías, A., Hernández-Arciniega, C. R., Cortés-Pérez, M., Chávez-López, E. L., García-Villalobos, G. G., Hinojosa-Heredia, H., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.06.004 · Cited by 42
“Although most new cases of type 2 diabetes mellitus occurred in older adults, the greatest relative increase in type 2 diabetes mellitus was observed in patients in their second decade of life.(16) Increasing numbers of youth-onset type 2 diabetes mellitus will also influence the incidence of diabetic kidney disease,…”
BackgroundRisk factors and predictive biomarkers of early cardiovascular disease in obese youth
Ho, H. C. H., Maddaloni, E., & Buzzetti, R. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3134 · Cited by 45
Tsai, C., Huang, T., & Tsai, M. (2017) · Experimental Physiology · doi:10.1113/ep086624 · Cited by 43
“Obesity in young adulthood has been associated with adverse neurocognitive effects and early onset of type 2 diabetes (D’Adamo & Caprio, 2011), and alterations in the lipid metabolism and chronic low-grade inflammation have been associated with neurodegenerative disorders, in particular with…”
BackgroundRapid Deterioration of Insulin Secretion in Obese Adolescents Preceding the Onset of Type 2 Diabetes
Elder, D. A., Hornung, L. N., Herbers, P. M., Prigeon, R. L., Woo, J. G., & D’Alessio, D. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.029 · Cited by 44
Karen Jenum, A., Sommer, C., Sletner, L., Mørkrid, K., Bærug, A., & Mosdøl, A. (2013) · Food & Nutrition Research · doi:10.3402/fnr.v57i0.18889 · Cited by 36
“A recent phenomenon is that T2DM is now diagnosed even in children and adolescents, strongly related to obesity, parental T2DM, and ethnicity (166).”
BackgroundHutchins, J., Barajas, R. A., Hale, D., Escaname, E., & Lynch, J. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12463 · Cited by 36
da Silva, C. D. C., Zambon, M. P., Vasques, A. C. J., Camilo, D. F., Antônio, M. Â. R. D. G. M., & Geloneze, B. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000533 · Cited by 45
“INTRODUCTION The increase in the prevalence of type 2 diabetes mellitus (1,2) and metabolic syndrome (3) in children and adolescents is an important public health concern.”
BackgroundChang, J., Chang, C., Chien, Y., Lin, S. S.-H., Cheng-Shiuan, T., Bai, C., & Chao, K. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-123 · Cited by 40
“IL10 plays a critical role in limiting inflammation and a switch in anti- and pro-inflammatory balance towards pro-inflammatory state in overweight and obese adolescents may promote the progression of normal glucose tolerance to insulin resistance in adulthood [30].”
BackgroundMethods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT)
Chen, M. E., Aguirre, R. S., & Hannon, T. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1023-3 · Cited by 41
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Research Progress on the Construction and Application of a Diabetic Zebrafish Model
Cao, Y., Chen, Q., Liu, Y., Jin, L., & Peng, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065195 · Cited by 40
Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth
SHAH, A. S., D’Alessio, D. A., Ford‐Adams, M., Desai, A. P., & Inge, T. H. (2016) · Diabetes Care · doi:10.2337/dc16-0067 · Cited by 38
Abdelwahed, O. M., Tork, O. M., el Din, M. G., Rashed, L. A., & Zickri, M. B. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.002 · Cited by 37
The changing face of paediatric diabetes
SHAH, A. S., & Nadeau, K. J. (2020) · Diabetologia · doi:10.1007/s00125-019-05075-6 · Cited by 41
Challenges in the diagnosis of diabetes type in pediatrics
Siller, A. F., Tosur, M., Relan, S., Astudillo, M., McKay, S. V., Dabelea, D., & REDONDO, M. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13070 · Cited by 37
“Moreover, pediatric T2D patients can quickly progress to a point of requiring insulin for glucose control.(66,67) In MODY, insulin reserve is only moderately decreased at onset(69,70) and thus the levels can overlap with those of individuals newly diagnosed with T1D in the partial remission phase, as well as those of…”
BackgroundAhsan, K. Z., Iqbal, A., Jamil, K., Haider, M. M., Khan, S., Chakraborty, N., & Streatfield, P. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279228 · Cited by 42
“Though diabetes is a progressive condition and blood glucose levels are known to increase with age, individuals diagnosed with type 2 diabetes at younger ages and being diabetic for a longer duration may, in the long run, have a more severe form of the disease and find it more difficult to achieve glycemic control wit…”
BackgroundLiu, L., Wang, F., Gracely, E. J., Moore, K., Melly, S. J., Zhang, F., Sato, P. Y., & Eisen, H. J. (2020) · Health Equity · doi:10.1089/heq.2020.0076 · Cited by 38
“They may have a higher degree of insulin resistance to current treatment modalities.(26) Further studies are needed to examine the age differences.”
BackgroundLi, G., Han, L., Wang, Y., Zhao, Y., Li, Y., Fu, J., Li, M., Gao, S., & Willi, S. M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020665 · Cited by 36
Admiraal, W. M., Holleman, F., Snijder, M. B., Peters, R. J. G., Brewster, L. M., Hoekstra, J. B. L., Stronks, K., & van Valkengoed, I. G. M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.014 · Cited by 31
“As it is well known that insulin resistance and beta-cell dysfunction are the two principal components involved in the pathophysiology of type 2 diabetes [18;19], this ethnic difference may be the result of either an ethnic disparity in progression of insulin resistance, or an ethnic disparity in progression of beta-c…”
BackgroundLiu, J., Liu, S., Gurung, R. L., Ang, K., Tang, W. E., Sum, C. F., Subramaniam, T., & Lim, S. C. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy211 · Cited by 36
Pandey, G. K., Balasubramanyam, J., Balakumar, M., Deepa, M., Anjana, R. M., Shiny, A., Anand, K., Velmurugan, K., Miranda, P., Balasubramanyam, M., et al. (2015) · Endocrine Practice · doi:10.4158/ep14558.or · Cited by 30
Younger-onset versus older-onset type 2 diabetes: Clinical profile and complications
Ranjit Unnikrishnan, I., Anjana, R. M., Amutha, A., Ranjani, H., Jebarani, S., Ali, M. K., Narayan, K. M. V., & Mohan, V. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.007 · Cited by 30
Mehreen, T. S., Kamalesh, R., Pandiyan, D., Kumar, D. S., Anjana, R. M., Mohan, V., & Ranjani, H. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0109 · Cited by 31
Insulin resistance in type 2 diabetic youth
Mizokami‐Stout, K., Cree‐Green, M., & Nadeau, K. J. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283557cd5 · Cited by 35
Measuring β-Cell Function Relative to Insulin Sensitivity in Youth
Sjaarda, L. A., Lee, S., Tfayli, H. M., Bacha, F. F., Bertolet, M. H., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-1508 · Cited by 37
“We (4,22) and others (32,33) have reported that DI decreases progressively across the spectrum of deteriorating glycemia in youth.”
BackgroundNielsen, R. E., Laursen, M. F., Vernal, D. L., Bisgaard, C., Jakobsen, H. N., Steinhausen, H., & Correll, C. U. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.04.023 · Cited by 31
Bryant, M., Burton, W., Cundill, B., Farrin, A. J., Nixon, J., Stevens, J., Roberts, K., Foy, R., Rutter, H., Hartley, S., et al. (2017) · Trials · doi:10.1186/s13063-016-1732-3 · Cited by 31
Precision Nutrition and Childhood Obesity: A Scoping Review
Wu, Y., Perng, W., & Peterson, K. E. (2020) · Metabolites · doi:10.3390/metabo10060235 · Cited by 30
Classification and Diagnosis of Diabetes Mellitus
Dennedy, M. C., Rizza, R. A., & Dinneen, S. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00038-x · Cited by 29
Obesity and Diabetes: A Sword of Damocles for Future Generations
Angi, A., & Chiarelli, F. (2020) · Biomedicines · doi:10.3390/biomedicines8110478 · Cited by 32
Xu, Y., Jakobsson, K., Harari, F., Andersson, E. M., & Li, Y. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115525 · Cited by 34
Moody, E. C., Cantoral, A., Tamayo-Ortiz, M., Pizano-Zárate, M. L., Schnaas, L., Kloog, I., Oken, E., Coull, B., Baccarelli, A., Téllez-Rojo, M. M., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17643 · Cited by 27
Emergence of microneedles as a potential therapeutics in diabetes mellitus
Zahoor, I., Singh, S., Behl, T., Sharma, N., Naved, T., Subramaniyan, V., Fuloria, S., Fuloria, N. K., Bhatia, S., Al‐Harrasi, A., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17346-0 · Cited by 34
Kenney, A., Chambers, R. A., Rosenstock, S., Neault, N. B., Richards, J. R., Reid, R., Nelson, L., Begay, M., Grass, R., Parker, S., et al. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716658357 · Cited by 27
“Both physiologic findings are relevant because new evidence indicates that progression of insulin resistance to T2DM is faster in obese children vs adults.(14) Interventions that can effectively reduce obesity and blood glucose levels are urgent for the youth population and will help curb rising health care costs of o…”
BackgroundYeow, T. P., Pacini, G., Tura, A., Hor, C. P., Lim, S. L., Tan, F. H. S., Tong, C. V., Hong, J. Y. H., Zain, F. M., Holst, J. J., et al. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000352 · Cited by 26
Wu, F., Juonala, M., Pitkänen, N., Jula, A., Lehtimäki, T. J., Sabin, M. A., Pahkala, K., Hutri‐Kähönen, N., Kähönen, M. A. P., Laitinen, T. P., et al. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1399446 · Cited by 29
Fatima, S., Akhtar, M. F., Ashraf, K. M., Sharif, A., Saleem, A., Akhtar, B., Peerzada, S., Shabbir, M., Ali, S., & Ashraf, W. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.2.8 · Cited by 27
“Recent studies have shown that the pre-diabetes and diabetes do not occur until the peripheral resistance of insulin is not compensated by pancreatic beta cells (6).”
BackgroundChien, H.-J., Peng, S.-J., Hua, T.-E., Kuo, C.-H., Juang, J.-H., & Tang, S.-C. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.224 · Cited by 25
Metadata
- Authors
- D’Adamo, E., & Caprio, S.
- Affiliations
- Yale University (US)
- Corresponding author
- Caprio, Sonia
- ORCID
- Caprio, Sonia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-04-22
- Volume
- 34
- Issue
- Supplement_2
- Pages
- S161-S165
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3632155
- OpenAlex
- W2114855885
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 30 · 2020: 29 · 2019: 24 · 2018: 33 · 2017: 33 · 2016: 39 · 2015: 22 · 2014: 26 · 2013: 11 · 2012: 12
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- F. Hoffmann-La Roche
- Georgia Clinical and Translational Science Alliance
- Novo Nordisk
- National Institutes of Health (and K24)
- National Center for Research Resources (UL1 RR0249139)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD- 28016, R01HD028016, R01-HD40787, K24HD001464, R01HD040787, K24-HD01464)
- Daiichi Sankyo Europe
- Cilag
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, youth, childhood obesity, adolescents, prediabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, insulin secretion, beta-cell function, natural history (disease), diabetes prevalence, cardiovascular complications
- MeSH terms
- Adolescent, Diabetes Mellitus, Type 2, Female, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.